Langley Holdings
Operations at one of the UK’s vital Covid-19 Test and Trace Lighthouse Laboratories are set for acceleration following the rapid and successful completion of complex leasing arrangements between Langley Holdings plc (Langley), headquartered in Retford, Nottinghamshire and Newcastle-upon-Tyne NHS Foundation Trust.
Advising Langley on the project was Knights plc’s Asset Management Team who completed a complex suite of documents between Langley and Newcastle-upon-Tyne NHS Foundation Trust.
Langley’s Baltic Park is a new 6-acre industrial and warehousing development in Gateshead. It was identified as an ideal facility for a Lighthouse Laboratory following the announcement of plans for a North East testing centre in September 2020.
The Lighthouse Laboratory will serve a hugely critical role in combating the Covid-19 pandemic in the region. The Gateshead facility will be leased for 5 years
William Langley, Director, Langley Holdings plc, said: « Langley is privileged to be involved in this vital public health project in the battle against Covid-19. We are grateful to the Knights plc team for their dedication and focus on the swift completion of these complex negotiations. ».
Erin Vickers, Partner, Knights plc, said: “This was a time-critical and sensitive project for all parties concerned. Our priority was to ensure a smooth negotiation process with the best possible outcome for our client and its tenants”.
The multimillion-pound Lighthouse Laboratory development was approved by Health Secretary Matt Hancock. It will strengthen the region’s resilience and response to the Coronavirus pandemic. The project is expected to create up to 1,000 local jobs.
One of 6 ‘Lighthouse’ Covid-19 testing laboratories being built in the UK at the group’s Baltic Park commercial property development in the northeast of England.
About Lighthouse Laboratories
A Lighthouse Laboratory is a high throughput facility that is dedicated to COVID-19 testing for the National Testing Programme.
The Lighthouse Laboratories were set up by experienced scientific executives and technical leaders with decades of experience. The rapid and sustained growth and independent quality assessments is evidence of this.
Each Lighthouse Laboratory has been reviewed by experts, and each has a clinical virology advisor.
The Lighthouse Laboratories are managed through the Department of Health and Social Care (DHSC), NHS trusts, commercial suppliers, academia and not-for-profit organisations.
About Langley
Langley Holdings plc (Langley) is a UK based, globally operating, multi-disciplined engineering and industrial manufacturing concern, principally providing capital equipment technologies to diverse markets around the world. Langley businesses occupy strong niche positions in their respective fields, providing advanced technologies in a solutions-based approach. The group comprises 7 divisions based principally in Germany, France and Italy and has a worldwide manufacturing and commercial footprint of several million square feet, with 17 production facilities in Germany, France, Italy, UK, the United States and Asia and more than 100 sales and service subsidiaries across Europe, the Americas, the Far East and Australasia.
The group was established in 1975 by Tony Langley, the current Chairman & CEO, and remains in family ownership.
